CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 62 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $47,000 | -7.8% | 12,594 | 0.0% | 0.01% | 0.0% |
Q1 2019 | $51,000 | +10.9% | 12,594 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $46,000 | -57.4% | 12,594 | 0.0% | 0.01% | -45.5% |
Q3 2018 | $108,000 | -92.3% | 12,594 | -81.3% | 0.01% | -93.3% |
Q1 2017 | $1,396,000 | – | 67,200 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADAMS STREET PARTNERS LLC | 3,275,616 | $8,746,000 | 1.82% |
Telemetry Investments, L.L.C. | 263,975 | $705,000 | 0.97% |
CHI Advisors LLC | 719,132 | $1,920,000 | 0.45% |
BVF INC/IL | 3,678,626 | $9,822,000 | 0.37% |
EcoR1 Capital, LLC | 3,579,377 | $9,557,000 | 0.36% |
Orbimed Advisors | 8,053,298 | $21,502,000 | 0.22% |
Stonepine Capital Management, LLC | 46,886 | $125,000 | 0.06% |
Ikarian Capital, LLC | 100,000 | $267,000 | 0.02% |
ALGERT GLOBAL LLC | 19,737 | $53,000 | 0.02% |
Windsor Creek Advisors, LLC | 14,786 | $39,000 | 0.01% |